Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effective Treatment with Tocilizumab in a Rheumatoid Arthritis Patient Complicated with Human T-cell Leukemia Virus Type 1-associated Myelopathy.
Iwao C, Umekita K, Miyauchi S, Kimura M, Rikitake Y, Iwao K, Rikitake M, Aizawa A, Kawaguchi T, Kariya Y, Matsuda M, Takajo I, Shiomi K, Okayama A. Iwao C, et al. Among authors: kariya y. Intern Med. 2020 Aug 1;59(15):1891-1897. doi: 10.2169/internalmedicine.4455-20. Epub 2020 Apr 23. Intern Med. 2020. PMID: 32321893 Free PMC article.
Neuropsychiatric Systemic Lupus Erythematosus with Cerebral Vasculitis and Lupus Nephritis Successfully Treated with High-dose Glucocorticoids and Mycophenolate Mofetil.
Tanaka S, Kawaguchi T, Kudo R, Kimura M, Rikitake Y, Iwao C, Rikitake M, Iwao K, Aizawa A, Kariya Y, Matsuda M, Miyauchi S, Takajo I, Umekita K. Tanaka S, et al. Among authors: kariya y. Intern Med. 2022 Oct 15;61(20):3131-3135. doi: 10.2169/internalmedicine.9123-21. Epub 2022 Mar 12. Intern Med. 2022. PMID: 35283391 Free PMC article.
The time-sequential changes of risk factors for adult T-cell leukemia development in human T-cell leukemia virus-positive patients with rheumatoid arthritis: a retrospective cohort study.
Umekita K, Hashiba Y, Kariya Y, Kubo K, Miyauchi S, Aizawa A, Umeki K, Nomura H, Kawaguchi T, Matsuda M, Takajo I, Hidaka T, Okayama A. Umekita K, et al. Among authors: kariya y. Mod Rheumatol. 2019 Sep;29(5):795-801. doi: 10.1080/14397595.2018.1519890. Epub 2018 Oct 25. Mod Rheumatol. 2019. PMID: 30246572
Human T-cell leukemia virus type 1 may invalidate T-SPOT.TB assay results in rheumatoid arthritis patients: A retrospective case-control observational study.
Umekita K, Hashiba Y, Iwao K, Iwao C, Kimura M, Kariya Y, Kubo K, Miyauchi S, Kudou R, Rikitake Y, Takajo K, Kawaguchi T, Matsuda M, Takajo I, Inoue E, Hidaka T, Okayama A. Umekita K, et al. Among authors: kariya y. PLoS One. 2020 May 27;15(5):e0233159. doi: 10.1371/journal.pone.0233159. eCollection 2020. PLoS One. 2020. PMID: 32459801 Free PMC article. Clinical Trial.
High incidence of serious infections requiring hospitalisation in human T-cell leukaemia virus type 1-positive rheumatoid arthritis: A case-controlled observational study.
Hashiba Y, Umekita K, Kimura M, Iwao C, Iwao K, Kariya Y, Kubo K, Miyauchi S, Kudou R, Rikitake Y, Kawaguchi T, Matsuda M, Takajo I, Inoue E, Hidaka T, Okayama A. Hashiba Y, et al. Among authors: kariya y. Mod Rheumatol. 2022 Aug 20;32(5):866-874. doi: 10.1093/mr/roab077. Mod Rheumatol. 2022. PMID: 34897491
Effectiveness and safety of non-tumor necrosis factor inhibitor therapy for anti-human T-cell leukemia virus type 1 antibody-positive rheumatoid arthritis.
Endo Y, Fukui S, Umekita K, Suzuki T, Miyamoto J, Morimoto S, Shimizu T, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Origuchi T, Okada A, Fujikawa K, Mizokami A, Matsuoka N, Aramaki T, Ueki Y, Eguchi K, Kariya Y, Hashiba Y, Hidaka T, Okayama A, Kawakami A, Nakamura H. Endo Y, et al. Among authors: kariya y. Mod Rheumatol. 2021 Sep;31(5):972-978. doi: 10.1080/14397595.2020.1847802. Epub 2020 Nov 27. Mod Rheumatol. 2021. PMID: 33161771
202 results